The food industry's strategy relies on ultra-processed meals that are cheap, easy to prepare, and delicious. Why would it change to a healthier model?
Hello. For a limited time, we're offering the first three months of our STAT+ subscription for $30. That's the price of like, two cocktails in New York City. Seems like a pretty sweet deal to me. Learn more here. —Alexa Lee, STAT newsletter strategist. |
|
|
She was told she might have cancer: How medicine pathologizes Black patients' normal test results Some patients arrive with nearly a dozen family members because they are fearing terrible news, one pediatric oncologist said. "Then they leave high-fiving each other and saying, 'It's just because we're Black,'" she said. Read more. By Katie Palmer and Usha Lee McFarling |
|
How a government scientist is pushing to supersize research into ultra-processed foods The food industry has staked its business model for decades on developing ultra-processed meals that are cheap, easy to prepare — and let's face it — delicious. Kevin Hall is investigating how this type of food could be affecting people in previously unknown ways. Read more. By Nicholas Florko José A. Alvarado Jr. for STAT A new drug offers a rare option for brain cancer treatment — and inspires hopes for more One of the first major brain tumor breakthroughs in decades has arrived. Now, researchers want to know if its use can be expanded to more advanced cancers. Read more. By Andrew Joseph In case you missed it... |
|
Check out more exclusive coverage with a STAT+ subscription | Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles. |
|
| STAT, 1 Exchange Place, Boston, MA | ©2024, All Rights Reserved. | |
|
No comments